a developer of drugs to combat various diseases
Industry Biotechnology
A.I.dvisor tells us that GALT and RNAC have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GALT and RNAC's prices will move in lockstep.
Ticker / NAME | Correlation To GALT | 1D Price Change % | ||
---|---|---|---|---|
GALT | 100% | -7.24% | ||
RNAC - GALT | 32% Poorly correlated | -6.02% | ||
SNPX - GALT | 32% Poorly correlated | -6.72% | ||
PMN - GALT | 26% Poorly correlated | -4.11% | ||
CRMD - GALT | 25% Poorly correlated | -6.41% | ||
HCWB - GALT | 24% Poorly correlated | -8.89% | ||
More |
Ticker / NAME | Correlation To GALT | 1D Price Change % |
---|---|---|
GALT | 100% | -7.24% |
biotechnology theme (248 stocks) | 13% Poorly correlated | +5.56% |
drugs theme (265 stocks) | 12% Poorly correlated | +5.37% |
diseases theme (42 stocks) | 8% Poorly correlated | +1.03% |